Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | JNJ-87562761 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on JNJ-87562761 (Dec 2024). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| JNJ-87562761 | JNJ 87562761|JNJ87562761 | Limited information is currently available on JNJ-87562761 (Dec 2024). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06604715 | Phase I | JNJ-87562761 | A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma | Recruiting | ESP | CAN | 2 |